Oncofertility pp 403-412 | Cite as

Counseling and Consenting Women with Cancer on Their Oncofertility Options: A Clinical Perspective

  • Emily S. JungheimEmail author
  • Kenneth R. Carson
  • Douglas Brown
Part of the Cancer Treatment and Research book series (CTAR, volume 156)


Over the past decade, professional and lay organizations have raised awareness of the damaging effects some cancer treatments can have on the fertility of young women. Despite this progress, counseling and consenting cancer patients about their fertility remains complicated. Literature from the American Society for Clinical Oncology [1] (ASCO) outlines treatment regimens that may affect fertility; however, these regimens continue to evolve, making it difficult to predict how an individual’s fertility may be compromised. After fertility counseling, some women elect to preserve gametes or embryos prior to cancer treatment, but doing so does not guarantee future fertility.


Assisted Reproductive Technology Fertility Preservation Embryo Cryopreservation Oocyte Cryopreservation Freeze Embryo Transfer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This research was supported by the Oncofertility Consortium NIH 8UL1DE019587, 5RL1HD058296.


  1. 1.
    Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006; 24(18):2917–31.PubMedCrossRefGoogle Scholar
  2. 2.
    Su HI, Sammel MD, Velders L, et al. Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors. Fertil Steril. 2009 (In press).Google Scholar
  3. 3.
    Practice Committee of Society for Assisted Reproductive Technology; Practice Committee of American Society for Reproductive Medicine. Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion. Fertil Steril. 2008; 90(5 Suppl):S134–5.Google Scholar
  4. 4.
    ACOG Committee Opinion No. 405: ovarian tissue and oocyte cryopreservation. Obstet Gynecol. 2008; 111(5):1255–6.Google Scholar
  5. 5.
    Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008; 90(5 Suppl):S241–6.Google Scholar
  6. 6.
    Thorn P. Recipient counseling for donor insemination. In: Covington S Ed. Infertility counseling. 2nd edn. New York: Cambridge University Press; 2006: 305–18.Google Scholar
  7. 7.
    Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology. Elements to be considered in obtaining informed consent for ART. Fertil Steril. 2006; 86(5 Suppl 1):S272–3.Google Scholar
  8. 8.
    Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005; 83(6):1622–8.CrossRefGoogle Scholar
  9. 9.
  10. 10.
    Partridge AH. Fertility preservation: a vital survivorship issue for young women with breast cancer. J Clin Oncol. 2008; 26(16):2612–3.PubMedCrossRefGoogle Scholar
  11. 11.
    Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008; 26(16):2630–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Practice Committee of Society for Assisted Reproductive Technology; Practice Committee of American Society for Reproductive Medicine. Guidelines on number of embryos transferred. Fertil Steril. 2008; 90(5 Suppl):S163–4.Google Scholar
  13. 13.
    Ryan GL, Sparks AE, Sipe CS, Syrop CH, Dokras A, Van Voorhis BJ. A mandatory single blastocyst transfer policy with educational campaign in a United States IVF program reduces multiple gestation rates without sacrificing pregnancy rates. Fertil Steril. 2007; 88(2):354–60.PubMedCrossRefGoogle Scholar
  14. 14.
    Crockin SL. Legal issues related to parenthood after cancer. J Natl Cancer Inst Monogr. 2005; 34:111–3.PubMedCrossRefGoogle Scholar
  15. 15.
    Lyerly AD, Steinhauser K, Voils C, et al. Fertility patients’ views about frozen embryo disposition: results of a multi-institutional US survey. Fertil Steril. 2008; 2.Google Scholar
  16. 16.
    Ethics Committee and ASRM. Posthumous reproduction. Fertil Steril. 2004; 82(Suppl 1):S260–2.Google Scholar
  17. 17.
    Practice Committee of American Society for Reproductive Medicine. Definition of “experimental”. Fertil Steril. 2008; 90(5 Suppl):S181.Google Scholar
  18. 18.
    Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009; 18(6):769–76.PubMedCrossRefGoogle Scholar
  19. 19.
    Cancer and Fertility Referral Guide. Accessed September 2, 2009.
  20. 20.
    Andersen CY, Rosendahl M, Byskov AG, et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod. 2008; 23(10):2266–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Bedaiwy MA, El-Nashar SA, El Saman AM, et al. Reproductive outcome after transplantation of ovarian tissue: a systematic review. Hum Reprod. 2008; 23(12):2709–17.PubMedCrossRefGoogle Scholar
  22. 22.
    Demeestere I, Simon P, Buxant F, et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod. 2006; 21(8):2010–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004; 364(9443):1405–10.PubMedCrossRefGoogle Scholar
  24. 24.
    Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005; 353(3):318–21.PubMedCrossRefGoogle Scholar
  25. 25.
    Washington University in St. Louis, HRPO Behavioral Minimal Risk Subcommittee REVIEWER’S GUIDE. Scholar
  26. 26.
    Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000; 283(20):2701–11.PubMedCrossRefGoogle Scholar
  27. 27.
    Levine RJ. Consent issues in human research. In: Post SG Ed. Encyclopedia of bioethics. 3rd edn. New York: Macmillan Reference; 2001: 1280–90.Google Scholar
  28. 28.
    US Department of Health and Human Services, Office of Human Research Protections: Title 45 CFR 46. Accessed April 28, 2009.

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Emily S. Jungheim
    • 1
    Email author
  • Kenneth R. Carson
    • 2
  • Douglas Brown
    • 3
  1. 1.Department of Reproductive Endocrinology and InfertilityBarnes-Jewish Hospital, Washington University School of MedicineSt. LouisUSA
  2. 2.Department of Hematology and OncologyBarnes-Jewish Hospital, Washington University School of MedicineSt. LouisUSA
  3. 3.Barnes-Jewish Hospital Ethics ProgramBarnes-Jewish Hospital, Washington University School of MedicineSt. LouisUSA

Personalised recommendations